Abstract
PPARγ agonists synergize with the BCR–ABL inhibitor imatinib to deplete the CML stem cell pool.
©2015 American Association for Cancer Research.
2015
You do not currently have access to this content.
Skip Nav Destination
Article navigation
1 November 2015
Research Watch|
November 01 2015
PPARγ Agonists Deplete the Chronic Myeloid Leukemia Stem Cell Pool Available to Purchase
Cancer Discov (2015) 5 (11): 1120.
RSS Feeds